BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37822117)

  • 1. Factors predicting the progression from paroxysmal to persistent atrial fibrillation despite an index catheter ablation.
    Li GY; Elimam AM; Lo LW; Lin YJ; Chang SL; Hu YF; Chung FP; Chao TF; Lin CY; Liu CM; Liao JN; Ton AK; Yugo D; Lin L; Tuan TC; Kao PH; Liu SH; Chhay C; Kuo L; Cheng WH; Chen WT; Chen SA
    J Cardiovasc Electrophysiol; 2023 Dec; 34(12):2504-2513. PubMed ID: 37822117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of patients with paroxysmal atrial fibrillation and severe left atrial scarring: comparison between pulmonary vein antrum isolation only or pulmonary vein isolation combined with either scar homogenization or trigger ablation.
    Mohanty S; Mohanty P; Di Biase L; Trivedi C; Morris EH; Gianni C; Santangeli P; Bai R; Sanchez JE; Hranitzky P; Gallinghouse GJ; Al-Ahmad A; Horton RP; Hongo R; Beheiry S; Elayi CS; Lakkireddy D; Madhu Reddy Y; Viles Gonzalez JF; Burkhardt JD; Natale A
    Europace; 2017 Nov; 19(11):1790-1797. PubMed ID: 28039211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary vein reconnection and arrhythmia progression after antral linear catheter ablation of paroxysmal and persistent atrial fibrillation.
    Wasmer K; Dechering DG; Köbe J; Mönnig G; Pott C; Frommeyer G; Lange PS; Kochhäuser S; Eckardt L
    Clin Res Cardiol; 2016 Sep; 105(9):738-43. PubMed ID: 27048420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, long-term outcomes and predictors of recurrence following a single catheter ablation procedure for atrial fibrillation.
    Efremidis M; Letsas KP; Georgopoulos S; Karamichalakis N; Vlachos K; Lioni L; Bazoukis G; Saplaouras A; Sakellaropoulou A; Kolokathis AM; Rokiza A; Anagnostou A; Valkanas K; Sideris A
    Acta Cardiol; 2019 Aug; 74(4):319-324. PubMed ID: 30303043
    [No Abstract]   [Full Text] [Related]  

  • 5. Characteristics and long-term catheter ablation outcome in long-standing persistent atrial fibrillation patients with non-pulmonary vein triggers.
    Hung Y; Lo LW; Lin YJ; Chang SL; Hu YF; Chung FP; Tuan TC; Chao TF; Liao JN; Walia R; Te ALD; Yamada S; Lin CH; Chang YT; Lin CY; Chan CS; Liao YC; Raharjo S; Allamsetty S; Chen SA
    Int J Cardiol; 2017 Aug; 241():205-211. PubMed ID: 28456483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right atrial diameter and outcome of catheter ablation of atrial fibrillation.
    Wen S-; Liu N; Bai R; Tang RB; Yu RH; Long DY; Sang CH; Jiang CX; Li SN; Wu JH; Ruan YF; Hu R; Du X; Liu XH; Dong JZ; Ma CS
    J Interv Card Electrophysiol; 2017 Aug; 49(2):157-164. PubMed ID: 28612230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventional management of recurrent paroxysmal atrial fibrillation despite isolated pulmonary veins: impact of an ablation strategy targeting inducible atrial tachyarrhythmias.
    Sultan A; Lüker J; Hoffmann B; Servatius H; Schäffer B; Steven D; Willems S
    Europace; 2016 Jul; 18(7):994-9. PubMed ID: 26462703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheter ablation of persistent atrial fibrillation with and without a history of paroxysmal atrial fibrillation.
    Miao CL; Yin XD; Dong JZ; Liu XP; Yu RH; Long DY; Tang RB; Sang CH; Ma CS
    Chin Med J (Engl); 2012 Mar; 125(6):1175-8. PubMed ID: 22613550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of nonpulmonary vein foci in catheter ablation for paroxysmal atrial fibrillation.
    Hayashi K; An Y; Nagashima M; Hiroshima K; Ohe M; Makihara Y; Yamashita K; Yamazato S; Fukunaga M; Sonoda K; Ando K; Goya M
    Heart Rhythm; 2015 Sep; 12(9):1918-24. PubMed ID: 25962801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA.
    Monahan KH; Bunch TJ; Mark DB; Poole JE; Bahnson TD; Al-Khalidi HR; Silverstein AP; Daniels MR; Lee KL; Packer DL;
    Europace; 2022 Oct; 24(9):1430-1440. PubMed ID: 35640922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Pulmonary Vein Anatomy on the Outcomes of Catheter Ablation for Atrial Fibrillation.
    Istratoaie S; Roșu R; Cismaru G; Vesa ȘC; Puiu M; Zdrenghea D; Pop D; Buzoianu AD
    Medicina (Kaunas); 2019 Nov; 55(11):. PubMed ID: 31690031
    [No Abstract]   [Full Text] [Related]  

  • 12. nMARQ Ablation for Atrial Fibrillation: Results from a Multicenter Study.
    Mahida S; Hooks DA; Nentwich K; Ng GA; Grimaldi M; Shin DI; Derval N; Sacher F; Berte B; Yamashita S; Denis A; Hocini M; Deneke T; Haissaguerre M; Jais P
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):724-9. PubMed ID: 25916682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of the 2nd generation cryoballoon for pulmonary vein isolation in patients with persistent atrial fibrillation - A sub-study of the randomized trial evaluating single versus dual cryoballoon applications.
    Mörtsell D; Jansson V; Malmborg H; Lönnerholm S; Blomström-Lundqvist C
    Int J Cardiol; 2019 Mar; 278():120-125. PubMed ID: 30409738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-center experience of the FIRM technique to ablate paroxysmal and persistent atrial fibrillation.
    Henley P; Foreman JR; Padanilam BJ; Nair GV; Olson JA; Joshi S; Aziz Z; Foster T; Prystowsky EN
    J Cardiovasc Electrophysiol; 2019 Apr; 30(4):493-502. PubMed ID: 30580474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent atrial fibrillation presenting in sinus rhythm: pulmonary vein isolation versus pulmonary vein isolation plus electrogram-guided ablation.
    Sebag FA; Chaachoui N; Linton NW; Amraoui S; Harrison J; Williams S; Rinaldi AC; Gill J; Cooklin M; Kirubakaran S; O'Neill MD; Wright M; Lellouche N
    Arch Cardiovasc Dis; 2013 Oct; 106(10):501-10. PubMed ID: 24070597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of left atrium epicardial adipose tissue on recurrence after catheter ablation in patients with different types of atrial fibrillation.
    Sang C; Hu X; Zhang D; Shao Y; Qiu B; Li C; Li F; Zhang C; Wang Z; Chen M
    Int J Cardiol; 2023 May; 379():33-39. PubMed ID: 36893857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of pulmonary veins isolation radiofrequency time and the evolution of left atrium volume on a twelve-year observational follow-up of paroxysmal atrial fibrillation patients.
    Buffle E; Johner N; Namdar M; Shah D
    Indian Heart J; 2022; 74(2):120-126. PubMed ID: 35101393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy of catheter ablation for paroxysmal atrial fibrillation in patients with Brugada syndrome and an implantable cardioverter-defibrillator to prevent inappropriate shock therapy.
    Kitamura T; Fukamizu S; Kawamura I; Hojo R; Aoyama Y; Komiyama K; Nishizaki M; Hiraoka M; Sakurada H
    Heart Rhythm; 2016 Jul; 13(7):1455-9. PubMed ID: 26961302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of age on the outcome of cryoballoon ablation as the primary approach in the interventional treatment of atrial fibrillation: Insights from a large all-comer study.
    Hartl S; Dorwarth U; Pongratz J; Aurich F; Brück B; Tesche C; Ebersberger U; Wankerl M; Hoffmann E; Straube F
    J Cardiovasc Electrophysiol; 2021 Apr; 32(4):949-957. PubMed ID: 33644913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial volumetry from routine diagnostic work up prior to pulmonary vein ablation is a good predictor of freedom from atrial fibrillation.
    Sohns C; Sohns JM; Vollmann D; Lüthje L; Bergau L; Dorenkamp M; Zwaka PA; Hasenfuß G; Lotz J; Zabel M
    Eur Heart J Cardiovasc Imaging; 2013 Jul; 14(7):684-91. PubMed ID: 23435593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.